Latest Production News

Pacific Edge Limited reported a resilient FY25 performance despite losing Medicare coverage for its Cxbladder tests in the US, announcing a $20 million equity raise to support commercialization and growth.

Rare Foods Australia Limited has requested an immediate suspension of its shares on the ASX, paving the way for its voluntary removal from the exchange next month. This move follows shareholder approval earlier this year.

Wellnex Limited has withdrawn its recent announcement referencing a SP Angel research report containing forward-looking financial information, clarifying it does not endorse the projections.

EVE Health Group has successfully passed all shareholder resolutions at its recent General Meeting, paving the way for its acquisition of Nextract Pty Ltd and announcing significant leadership changes.

Vintage Energy has successfully completed a $2.1 million capital raise through fully subscribed Entitlement and Shortfall Offers, aiming to enhance gas output from its Cooper Basin fields.

Eden Innovations Ltd reports a striking 86% year-on-year sales increase for its EdenCrete® Pz7 concrete admixture, driven by expanding installations in the US, Ecuador, Mexico, and Canada. The company’s innovative product is gaining traction for its cost-saving and environmental benefits in the construction sector.

Cobalt Blue Holdings has secured a pivotal three-year contract with Glencore to supply up to 50% of feedstock for its upcoming Kwinana Cobalt Refinery, marking a major step in advancing Australia's critical minerals ambitions.

Streamplay Studio Limited has had its ASX trading suspension lifted following a significant announcement about a new agreement with a gaming platform, signaling renewed investor interest.

Regal Partners Limited reported a stellar 2024 with a 141% jump in average funds under management to $14.4 billion and a near tripling of net profit after tax. Strategic acquisitions and offshore expansion underpin its growth trajectory.

TruScreen Group Limited has announced a capital raising initiative involving Placement and Share Purchase Plan (SPP) Options, aiming to secure approximately NZ$3 million to fund strategic growth and working capital needs. The offer, subject to shareholder approval, includes up to 80.9 million Placement Options and 55.5 million SPP Options exercisable at A$0.02.

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

TruScreen Group Limited has launched a NZ$1.22 million Share Purchase Plan offering discounted shares to eligible investors, aiming to fuel growth in key international markets and public health initiatives.